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Abstract
Inferior vena cava (IVC) involvement in retroperitoneal malignancies is a rare occurrence and radical surgery with major
vascular resection represents the only potential curative treatment. IVC replacement after resection is still controversial and
only small series and few prospective data are available. We report a series of three patients affected by retroperitoneal masses
involving IVC treated with vena cava resection without replacement. All patients were treated by a radical R0 surgical procedure
associated with infrarenal IVC resection and no reconstruction. Based on preoperative radiologic imaging and intraoperative
findings, one patient also underwent right nephrectomy, while another patient underwent left renal vein ligation without
nephrectomy. Neither early nor late severe post-operative complications related to the absence of IVC outflow were observed.
Resection without replacement of the infrarenal IVC results in acceptable morbidity, thus specific risks related to the use of
prosthetic grafts can be avoided.
INTRODUCTION
Retroperitoneal tumors are an heterogeneous group of diseases,
and malignant lesions are more frequent than benign lesions.
Renal cell carcinomas, retroperitoneal liposarcomas, leiomyosar-
comas and retroperitoneal metastatic lymph nodes from testic-
ular carcinoma represent the most common malignancies of this
district. Radical surgery (R0) represents the only potential cura-
tive treatment, even if the prognosis remains poor. Inferior vena
cava (IVC) involvement is uncommon and, when occurs, major
vascular resection may be necessary to achieve radical resection
with negative margins. IVC reconstruction after resection is still
controversial.
CASE REPORTS
The authors report three consecutive cases of patients affected
by retroperitoneal malignancy with IVC involvement who were
treated at our Institution with radical R0 resection.
Case 1 was a 33-year-old male affected by a right testicular
germ-cell tumor with enlarged retroperitoneal lymph nodes
surrounding the infrarenal IVC. The patient underwent orchifu-
nicolectomy and subsequent chemotherapy based on bleomycin,
etoposide and platinum. A restaging computed tomography (CT)
scan showed partial response and confirmed residual tumor
involving both the IVC (with occluding thrombus) and the
distal left renal vein (LRV) (Fig. 1A). CT scan also showed an
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Figure 1: (A) CT scan (coronal section) of the retroperitoneal mass (asterisk) involving the IVC and LRV with congested gonadal vessels; (B) cross-section CT scan showing
well-represented collateral outflow (arrow) of the renal–azygos–lumbar system.
efficient venous collateral pathway through the azygos−lumbar
system (Fig. 1B), with no clinically evident lower limb edema. The
patient underwent an en-bloc resection of the tumor mass with
infrarenal IVC and LRV ligation without nephrectomy; no IVC
prosthetic replacement was carried out. Recovery from surgery
was uneventful with the exception of transient mild renal
failure treated conservatively and without the need for dialysis.
Renal ultrasonography showed regular bilateral parenchymal
perfusion, and doppler ultrasonography of the lower limbs
confirmed normal superficial and deep venous outflow. The
patient was discharged 9 days after surgery. Histology showed a
teratoma with alpha-fetoprotein expression and extensive post-
chemotherapy areas of necrosis.
Case 2 was a 23-year-old male with a testicular germ-cell
tumor and evidence of pathologically enlarged abdominal and
cervical lymph nodes. After surgical excision of the primary
tumor and administration of four cycles of Bleomycin, Etopo-
side and Platinum (cisplatin) (BEP) + four cycles of paclitaxel,
ifosfamide and cis-platinum at another institution, the patient
was referred to us. CT scan showed stable disease with a large
infrarenal inter-aortocaval mass (13 × 10 cm) obstructing the
IVC (Fig. 2A). Extensive abdominal lymphadenectomy and resec-
tion of the infrarenal IVC without prosthetic replacement was
performed (Fig. 2B). Concurrently, ear−nose and throat surgeons
performed modified radical left neck lymphadenectomy. The
post-operative course was characterized by transient renal fail-
ure and moderate anemia requiring blood transfusions and rehy-
dration therapy. The patient was discharged 13 days later and
had normal renal function values and no relevant inferior limb
edema. Histology confirmed the diagnosis of lymph node metas-
tases of the germ cell tumor.
Case 3 was a 65-year-old woman with a 9 × 7 cm retroperi-
toneal mass infiltrating the right kidney and the IVC with radi-
ologic evidence of IVC and right ureteral obstruction (Fig. 2C).
Percutaneous biopsy was compatible with angiomyosarcoma.
Clinical examination showed no edema of the lower limbs. Neo-
adjuvant chemoradiotherapy (doxorubicin + dacarbazine fol-
lowed by 50 Gy in 25 fractions) was performed. Post-treatment
positron emission tomography scan imaging showed stable dis-
ease with partial metabolic response. Subsequently, the patient
underwent radical resection of the tumor with right nephrec-
tomy and infrarenal IVC resection. No IVC reconstruction was
performed and at surgery, venous outflow through a collat-
eral venous lumbar vein was noticed and preserved (Fig. 2D,
circle). No major perioperative complications occurred. Post-
operative ultrasonography revealed normal lower limb venous
pathways and the patient was discharged on post-operative
day 11. Histological examination confirmed a leiomyosarcoma
grade 2 Fédération Nationale des Centres de Lutte Contre Le
Cancer (FNCLCC criteria) with large post-chemotherapy areas of
necrosis.
DISCUSSION
Involvement of the IVC in retroperitoneal malignancies is
an uncommon event. The most often represented tumors in
these clinical situations are renal cell carcinomas followed
by leiomyosarcoma and testicular cancer [1]. Prognosis is
generally poor and the only possible curative treatment is
R0 resection with associated vascular resection if needed [2–
4]. Due to the rarity of this clinical presentation, there is no
unanimous agreement about the surgical management of the
IVC resection. Tumors involving less than 180◦ of the vascular
wall are usually managed by venous tangential resections.
Circumferential resections may be necessary in some cases in
order to achieve oncological radicality and in particular, vascular
replacement with homo- or allograft is usually performed in
case of suprarenal IVC resection [5]. On the contrary, surgery
for infrarenal IVC involvement is more frequently managed
by venous resection without venous reconstruction [5, 6]. This
approach may be taken into consideration in order to reduce
the likelihood of life-threatening, graft-related complications
such as early or late thrombosis, infections or anastomotic
leakage. The presence of a complete preoperative IVC occlusion,
the absence of lower limb swelling at clinical presentation,
or radiologic or intraoperative evidence of venous collateral
outflow through a renal–azygos–lumbar pathway should be
evaluated before vena cava prosthetic replacement [7, 8]. The
advantage of avoiding vascular graft replacement may be
considerable, especially in patients undergoing multiorgan
resection or in those being treated with neoadjuvant chemo-
or chemo-radiation therapy, which are the risk factors for post-
operative complications. Although significant prospective data
are not available due to the rarity of this scenario, various case
series are in favor of this technique [5, 6, 8]. In accordance
with these reports, our three cases have shown an acceptable
degree of morbidity without long-term sequela or mortality
and with a median hospital stay of 11 days. The six month
follow-up visits showed no signs of deep vein thrombosis or
renal failure in any of the three patients. In conclusion, although
our experience was related to a limited number of patients, we
believe that in carefully selected patients, infrarenal IVC ligation
after resection is a safe procedure and may reduce graft-related
complications.
Inferior vena cava resection without reconstruction for retroperitoneal malignancies 3
Figure 2: (A) Pre-operative CT scan with a large lesion involving the IVC; (B) intraoperative view showing ligation of the IVC with renal-vein preservation; (C) coronal CT
scan with a huge retroperitoneal space-occupying lesion infiltrating the right kidney and occluding the IVC; (D) intraoperative image after right nephrectomy and IVC
resection showing a large collateral lumbar trunk (circle).
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